Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype

Cancer Cell

Volumn 10, Issue 5, 2006, Pages 413-423

  Holmquist Mengelbier, Linda ^a   Fredlund, Erik ^a   Löfstedt, Tobias ^a   Noguera, Rosa ^b   Navarro, Samuel ^b   Nilsson, Helén ^a   Pietras, Alexander ^a   Vallon Christersson, Johan ^c   Borg, Åke ^c   Gradin, Katarina ^d   Poellinger, Lorenz ^d   Påhlman, Sven ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF VALENCIA   (Spain)

^c LUND UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CELLCYCLE

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; OXYGEN; VASCULOTROPIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 2, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR 2, ALPHA SUBUNIT; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CANCER GROWTH; CAPILLARY; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE ACTIVATION; GENE CONTROL; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; KNOCKOUT GENE; MAJOR CLINICAL STUDY; MOUSE; NEUROBLASTOMA; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; TUMOR GROWTH; VASCULARIZATION; ANIMAL; ANOXIA; CANCER TRANSPLANTATION; CELL CULTURE; CHILD; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHILD; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYGEN; PHENOTYPE; PROCOLLAGEN-PROLINE DIOXYGENASE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 33750630119     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.08.026     Document Type: Article

References (57)

1. Acker T., Diez-Juan A., Aragones J., Tjwa M., Brusselmans K., Moons L., Fukumura D., Moreno-Murciano M.P., Herbert J.M., Burger A., et al. Genetic evidence for a tumor suppressor role of HIF-2α. Cancer Cell 8 (2005) 131-141
2. Andersson A.C., Venables P.J., Tonjes R.R., Scherer J., Eriksson L., and Larsson E. Developmental expression of HERV-R (ERV3) and HERV-K in human tissue. Virology 297 (2002) 220-225
3. Blancher C., Moore J.W., Talks K.L., Houlbrook S., and Harris A.L. Relationship of hypoxia-inducible factor (HIF)-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res. 60 (2000) 7106-7113
4. Brown J.M., and Wilson W.R. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4 (2004) 437-447
5. Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet. 5 (2004) 27
6. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 69 Suppl. 3 (2005) 4-10
7. Chakrabarti J., Turley H., Campo L., Han C., Harris A.L., Gatter K.C., and Fox S.B. The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br. J. Cancer 91 (2004) 954-958
8. Covello K.L., Simon M.C., and Keith B. Targeted replacement of hypoxia-inducible factor-1α by a hypoxia-inducible factor-2α knock-in allele promotes tumor growth. Cancer Res. 65 (2005) 2277-2286
9. Covello K.L., Kehler J., Yu H., Gordan J.D., Arsham A.M., Hu C.J., Labosky P.A., Simon M.C., and Keith B. HIF-2α regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20 (2006) 557-570
10. Dayan F., Roux D., Brahimi-Horn M.C., Pouyssegur J., and Mazure N.M. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1α. Cancer Res. 66 (2006) 3688-3698
11. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
12. 2 in tissue in vivo by EPR oximetry and microelectrodes. Adv. Exp. Med. Biol. 411 (1997) 543-549
13. Harris A.L. Hypoxia-A key regulatory factor in tumour growth. Nat. Rev. Cancer 2 (2002) 38-47
14. Höckel M., and Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. JNCI Cancer Spectrum. J. Natl. Cancer Inst. 93 (2001) 266-276
15. Hoehner J.C., Gestblom C., Hedborg F., Sandstedt B., Olsen L., and Påhlman S. A developmental model of neuroblastoma: Differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab. Invest. 75 (1996) 659-675
16. Holmquist L., Jögi A., and Påhlman S. Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells. Int. J. Cancer 116 (2005) 218-225
17. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., and Simon M.C. Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol. Cell. Biol. 23 (2003) 9361-9374
18. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95 (1998) 7987-7992
19. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 12 (1998) 149-162
20. Jain S., Maltepe E., Lu M.M., Simon C., and Bradfield C.A. Expression of ARNT, ARNT2, HIF1α, HIF2α and Ah receptor mRNAs in the developing mouse. Mech. Dev. 73 (1998) 117-123
21. Jensen R.L. Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg. Focus 20 (2006) E24
22. Jögi A., Øra I., Nilsson H., Lindeheim A., Makino Y., Poellinger L., Axelson H., and Påhlman S. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc. Natl. Acad. Sci. USA 99 (2002) 7021-7026
23. Jögi A., Vallon-Christersson J., Holmquist L., Axelson H., Borg A., and Påhlman S. Human neuroblastoma cells exposed to hypoxia: Induction of genes associated with growth, survival, and aggressive behavior. Exp. Cell Res. 295 (2004) 469-487
24. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., and Poellinger L. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274 (1999) 6519-6525
25. Kondo K., Kim W.Y., Lechpammer M., and Kaelin Jr. W.G. Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1 (2003) E83 10.1371/journal.pbio.0000083
26. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295 (2002) 858-861
27. Löfstedt T., Jögi A., Sigvardsson M., Gradin K., Poellinger L., Påhlman S., and Axelson H. Induction of ID2 expression by hypoxia-inducible factor-1: A role in dedifferentiation of hypoxic neuroblastoma cells. J. Biol. Chem. 279 (2004) 39223-39231
28. Mahon P.C., Hirota K., and Semenza G.L. FIH-1: A novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15 (2001) 2675-2686
29. Marxsen J.H., Stengel P., Doege K., Heikkinen P., Jokilehto T., Wagner T., Jelkmann W., Jaakkola P., and Metzen E. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases. Biochem. J. 381 (2004) 761-767
30. Miyazaki K., Kawamoto T., Tanimoto K., Nishiyama M., Honda H., and Kato Y. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J. Biol. Chem. 277 (2002) 47014-47021
31. Nilsson H., Jögi A., Beckman S., Harris A.L., Poellinger L., and Påhlman S. HIF-2α expression in human fetal paraganglia and neuroblastoma: Relation to sympathetic differentiation, glucose deficiency, and hypoxia. Exp. Cell Res. 303 (2005) 447-456
32. Park S.K., Dadak A.M., Haase V.H., Fontana L., Giaccia A.J., and Johnson R.S. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1α (HIF-1α): Role of cytoplasmic trapping of HIF-2α. Mol. Cell. Biol. 23 (2003) 4959-4971
33. Peng J., Zhang L., Drysdale L., and Fong G.H. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc. Natl. Acad. Sci. USA 97 (2000) 8386-8391
34. Petrella B.L., Lohi J., and Brinckerhoff C.E. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma. Oncogene 24 (2005) 1043-1052
35. Poellinger L., and Johnson R.S. HIF-1 and hypoxic response: The plot thickens. Curr. Opin. Genet. Dev. 14 (2004) 81-85
36. Raval R.R., Lau K.W., Tran M.G., Sowter H.M., Mandriota S.J., Li J.L., Pugh C.W., Maxwell P.H., Harris A.L., and Ratcliffe P.J. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol. Cell. Biol. 25 (2005) 5675-5686
37. Ryan H.E., Lo J., and Johnson R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17 (1998) 3005-3015
38. Saal L.H., Troein C., Vallon-Christersson J., Gruvberger S., Borg A., and Peterson C. BioArray Software Environment (BASE): A platform for comprehensive management and analysis of microarray data. Genome Biol. 3 (2002) SOFTWARE0003
39. Sato M., Tanaka T., Maemura K., Uchiyama T., Sato H., Maeno T., Suga T., Iso T., Ohyama Y., Arai M., et al. The PAI-1 gene as a direct target of endothelial PAS domain protein-1 in adenocarcinoma A549 cells. Am. J. Respir. Cell Mol. Biol. 31 (2004) 209-215
40. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
41. Sowter H.M., Raval R.R., Moore J.W., Ratcliffe P.J., and Harris A.L. Predominant role of hypoxia-inducible transcription factor (Hif)-1α versus Hif-2α in regulation of the transcriptional response to hypoxia. Cancer Res. 63 (2003) 6130-6134
42. Takahashi R., Kobayashi C., Kondo Y., Nakatani Y., Kudo I., Kunimoto M., Imura N., and Hara S. Subcellular localization and regulation of hypoxia-inducible factor-2α in vascular endothelial cells. Biochem. Biophys. Res. Commun. 317 (2004) 84-91
43. Talks K.L., Turley H., Gatter K.C., Maxwell P.H., Pugh C.W., Ratcliffe P.J., and Harris A.L. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157 (2000) 411-421
44. ten Berge R.L., Meijer C.J., Dukers D.F., Kummer J.A., Bladergroen B.A., Vos W., Hack C.E., Ossenkoppele G.J., and Oudejans J.J. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood 99 (2002) 4540-4546
45. Tian H., Hammer R.E., Matsumoto A.M., Russell D.W., and McKnight S.L. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12 (1998) 3320-3324
46. Uchida T., Rossignol F., Matthay M.A., Mounier R., Couette S., Clottes E., and Clerici C. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1α and HIF-2α expression in lung epithelial cells: Implication of natural antisense HIF-1α. J. Biol. Chem. 279 (2004) 14871-14878
47. van Houdt I.S., Oudejans J.J., van den Eertwegh A.J., Baars A., Vos W., Bladergroen B.A., Rimoldi D., Muris J.J., Hooijberg E., Gundy C.M., et al. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma. Clin. Cancer Res. 11 (2005) 6400-6407
48. Wang Z., Wang F., Wang W.Q., Gao Q., Wei W.L., Yang Y., and Wang G.Y. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J. Gastroenterol. 10 (2004) 550-554
49. Wang V., Davis D.A., Haque M., Huang L.E., and Yarchoan R. Differential gene up-regulation by hypoxia-inducible factor-1α and hypoxia-inducible factor-2α in HEK293T cells. Cancer Res. 65 (2005) 3299-3306
50. Warnecke C., Zaborowska Z., Kurreck J., Erdmann V.A., Frei U., Wiesener M., and Eckardt K.U. Differentiating the functional role of hypoxia-inducible factor (HIF)-1α and HIF-2α (EPAS-1) by the use of RNA interference: Erythropoietin is a HIF-2α target gene in Hep3B and Kelly cells. FASEB J. 18 (2004) 1462-1464
51. Wei J.S., Greer B.T., Westermann F., Steinberg S.M., Son C.G., Chen Q.R., Whiteford C.C., Bilke S., Krasnoselsky A.L., Cenacchi N., et al. Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res. 64 (2004) 6883-6891
52. Wenger R.H., Stiehl D.P., and Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci. STKE 2005 (2005) re12
53. Wiesener M.S., Turley H., Allen W.E., Willam C., Eckardt K.U., Talks K.L., Wood S.M., Gatter K.C., Harris A.L., Pugh C.W., et al. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α. Blood 92 (1998) 2260-2268
54. Wiesener M.S., Jurgensen J.S., Rosenberger C., Scholze C.K., Horstrup J.H., Warnecke C., Mandriota S., Bechmann I., Frei U.A., Pugh C.W., et al. Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J. 17 (2003) 271-273
55. Yeung H.Y., Lai K.P., Chan H.Y., Mak N.K., Wagner G.F., and Wong C.K. Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 146 (2005) 4951-4960
56. Yoshizuka N., Moriuchi R., Mori T., Yamada K., Hasegawa S., Maeda T., Shimada T., Yamada Y., Kamihira S., Tomonaga M., and Katamine S. An alternative transcript derived from the trio locus encodes a guanosine nucleotide exchange factor with mouse cell-transforming potential. J. Biol. Chem. 279 (2004) 43998-44004
57. Zheng M., Simon R., Mirlacher M., Maurer R., Gasser T., Forster T., Diener P.A., Mihatsch M.J., Sauter G., and Schraml P. TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am. J. Pathol. 165 (2004) 63-69